Muscle velocity recovery cycles in myopathy

被引:3
|
作者
Meldgaard, M. [1 ]
Kristensen, R. S. [1 ]
Z'Graggen, W. J. [2 ]
Tan, S. V. [3 ]
Sondergaard, K. [4 ]
Qerama, E. [1 ,5 ]
Andersen, H. [5 ,6 ]
Fuglsang-Frederiksen, A. [1 ,5 ]
Tankisi, H. [1 ,5 ,7 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Neurophysiol, Aarhus, Denmark
[2] Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurol & Neurosurg, Bern, Switzerland
[3] Guys & St Thomas NHS Fdn Trust, Dept Neurol & Neurophysiol, London, England
[4] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark
[5] Aarhus Univ, Inst Clin Med, Aarhus, Denmark
[6] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark
[7] Aarhus Univ Hosp, Dept Clin Neurophysiol, Palle Juul Jensens Blvd, Aarhus, Denmark
关键词
Muscle velocity recovery cycles; Frequency ramp; Electromyography; Inflammatory myopathy; Non -inflammatory myopathy; CRITICAL ILLNESS MYOPATHY; ACTION-POTENTIALS; MEMBRANE DYSFUNCTION; ELECTROMYOGRAPHY;
D O I
10.1016/j.clinph.2023.04.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To understand the pathophysiology of myopathies by using muscle velocity recovery cycles (MVRC) and frequency ramp (RAMP) methodologies. Methods: 42 patients with quantitative electromyography (qEMG) and biopsy or genetic verified myopathy and 42 healthy controls were examined with qEMG, MVRC and RAMP, all recorded from the anterior tibial muscle. Results: There were significant differences in the motor unit potential (MUP) duration, the early and late supernormalities of the MVRC and the RAMP latencies in myopathy patients compared to controls (p < 0.05 apart from muscle relatively refractory period (MRRP)). When dividing into subgroups, the above-mentioned changes in MVRC and RAMP parameters were increased for the patients with noninflammatory myopathy, while there were no significant changes in the group of patients with inflammatory myopathy. Conclusions: The MVRC and RAMP parameters can discriminate between healthy controls and myopathy patients, more significantly for non-inflammatory myopathy. MVRC differences with normal MRRP in myopathy differs from other conditions with membrane depolarisation. Significance: MVCR and RAMP may have a potential in understanding disease pathophysiology in myopathies. The pathogenesis in non-inflammatory myopathy does not seem to be caused by a depolarisation of the resting membrane potential but rather by the change in sodium channels of the muscle membrane. (c) 2023 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [21] Validity of multi-fiber muscle velocity recovery cycles recorded at a single site using submaximal stimuli
    Bostock, Hugh
    Tan, S. Veronica
    Boerio, Delphine
    Z'Graggen, Werner J.
    CLINICAL NEUROPHYSIOLOGY, 2012, 123 (11) : 2296 - 2305
  • [22] CHLORIDE CHANNELS IN MYOTONIA CONGENITA ASSESSED BY VELOCITY RECOVERY CYCLES
    Tan, S. Veronica
    Z'Graggen, Werner J.
    Boerio, Delphine
    Rayan, Dipa Raja
    Norwood, Fiona
    Ruddy, Deborah
    Howard, R.
    Hanna, Michael G.
    Bostock, Hugh
    MUSCLE & NERVE, 2014, 49 (06) : 845 - 857
  • [23] Velocity recovery cycles of C fibres innervating human skin
    Bostock, H
    Campero, M
    Serra, J
    Ochoa, J
    JOURNAL OF PHYSIOLOGY-LONDON, 2003, 553 (02): : 649 - 663
  • [24] Velocity recovery cycles of single C fibres innervating rat skin
    George, Annette
    Serra, Jordi
    Navarro, Xavier
    Bostock, Hugh
    JOURNAL OF PHYSIOLOGY-LONDON, 2007, 578 (01): : 213 - 232
  • [25] MEMBRANE DYSFUNCTION IN ANDERSEN-TAWIL SYNDROME ASSESSED BY VELOCITY RECOVERY CYCLES
    Tan, S. Veronica
    Z'Graggen, Werner J.
    BoErio, Delphine
    Rayan, Dipa L. Raja
    Howard, Robin
    Hanna, Michael G.
    Bostock, Hugh
    MUSCLE & NERVE, 2012, 46 (02) : 193 - 203
  • [26] THE VELOCITY RECOVERY FUNCTION IN DIRECTLY ACTIVATED HUMAN-MUSCLE FIBERS
    DEMATTEI, M
    BERGAMINI, L
    CONTEGIACOMO, V
    TRONI, W
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1985, 61 (03): : S58 - S58
  • [27] Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over study
    Ruijs, Titia Q.
    Koopmans, Ingrid W.
    de Kam, Marieke L.
    Tannemaat, Martijn R.
    Groeneveld, Geert Jan
    Heuberger, Jules A. A. C.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (12): : 2971 - 2981
  • [28] Hypothyroid Myopathy with Muscle Pseudohypertrophy
    Sivagurunathan, Kajananan
    Jegathesan, Nalayini
    NEW ENGLAND JOURNAL OF MEDICINE, 2025,
  • [29] Muscle ultrasound in Bethlem myopathy
    Bönnemann, CG
    Brockmann, K
    Hanefeld, F
    NEUROPEDIATRICS, 2003, 34 (06) : 335 - 336
  • [30] Muscle hypertrophy in amyloid myopathy
    Tasca, Giorgio
    Modoni, Anna
    Nicoletti, Tommaso
    Monforte, Mauro
    Cuccaro, Annarosa
    Ricci, Enzo
    NEUROMUSCULAR DISORDERS, 2019, 29 (02) : 150 - 151